Feasibility Study of 2 Parallel Phases II Pre or Postgastrectomy in Patients With Gastric Cancer (FOLFIRI-radiotherapy Plus 5 Fluorouracil-surgery or Surgery-FOLFIRI-radiotherapy Plus 5 Fluorouracil)
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
feasibility of treatment
at the end of the treatment
Yes
MICHEL Pierre, MD
Principal Investigator
University Hospital, Rouen
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
2006/097/HP
NCT00512304
August 2007
Name | Location |
---|